Lead Product(s) : Ytterbium-176
Therapeutic Area : Oncology
Study Phase : Undisclosed
Sponsor : Point Biopharma
Deal Size : Undisclosed
Deal Type : Agreement
Details : With this agreement with Kinectrics, POINT to access large quantities of highly enriched Yb-176, creating the world’s first, stable North American supply of n.c.a. Lu-177, thereby establishing POINT as a dependable provider of high-quality radiopharmac...
Product Name : Yb-176
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
October 29, 2021
Lead Product(s) : Ytterbium-176
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Sponsor : Point Biopharma
Deal Size : Undisclosed
Deal Type : Agreement